Clay Thorp's Net Worth
$80 Thousand
Who is Clay Thorp?
Clay Thorp does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Vigil Neuroscience, Inc., G1 Therapeutics, Inc., PhaseBio Pharmaceuticals Inc, and Clearside Biomedical, Inc..
SEC CIK
Clay Thorp's CIK is 0001592380
Past Insider Trading and Trends
2022 was Clay Thorp's most active year for acquiring shares with 6 total transactions. Clay Thorp's most active month to acquire stocks was the month of May. 2021 was Clay Thorp's most active year for disposing of shares, totalling 1 transactions. Clay Thorp's most active month to dispose stocks was the month of January. 2021 saw Clay Thorp paying a total of $30,000.00 for 49,000 shares, this is the most they've acquired in one year. In 2021 Clay Thorp cashed out on 32,873 shares for a total of $145,627.39, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Clearside Biomedical, Inc. (CLSD) Snapshot price: $0.9799
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +32.76% | 10K |
$0.86 | $8,600.00 | 40.52K |
Sep 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +84.74% | 14K |
$1.02 | $14,266.00 | 30.52K |
Dec 21
| |||
Form 4
| -28.19% | -1.40M |
—
|
—
| 3.56M |
Dec 15
| |||
Form 4/A
| -0.66% | -32.87K |
$4.43 | -$145,627.39 | 4.95M |
Scheduled
|
Feb 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| -0.95% | -32.87K |
$4.43 | -$145,627.39 | 3.43M |
Scheduled
|
Feb 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| +43.79% | 1.52M |
$1.05 | $1,599,999.40 | 4.98M |
Nov 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
∞
| 8K |
$1.36 | $10,880.00 | 8K |
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| -4.44% | -161.14K |
$13.08 | -$2,107,589.24 | 3.47M |
May 17 - May 18
| |||
Form 4
| -3.69% | -138.86K |
$12.21 | -$1,695,790.72 | 3.63M |
Mar 21 - Mar 23
| |||
Form 4
| -0.92% | -35.00K |
$6.22 | -$217,550.00 | 3.77M |
Scheduled
|
Dec 5 - Dec 7
| ||
Form 4
| -0.91% | -35.00K |
$7.00 | -$245,100.00 | 3.8M |
Scheduled
|
Nov 14 - Nov 16
| ||
Form 4
| -0.90% | -35.00K |
$8.57 | -$299,900.00 | 3.84M |
Scheduled
|
Oct 3 - Oct 5
| ||
Form 4
| -0.63% | -24.50K |
$7.52 | -$184,185.00 | 3.87M |
Scheduled
|
Sep 13 - Sep 15
| ||
Form 4
| -0.62% | -24.50K |
$7.57 | -$185,490.00 | 3.9M |
Scheduled
|
Aug 7 - Aug 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| -0.61% | -24.00K |
$8.36 | -$200,610.00 | 3.92M |
Scheduled
|
May 18 - May 19
| ||
Form 4
| -1.12% | -44.48K |
$8.63 | -$384,096.38 | 3.94M |
Scheduled
|
May 15 - May 17
| ||
Form 4
| -1.69% | -68.48K |
$7.46 | -$510,944.50 | 3.99M |
Scheduled
|
Apr 17 - Apr 19
| ||
Form 4
| -1.66% | -68.48K |
$6.56 | -$449,543.45 | 4.06M |
Scheduled
|
Mar 15 - Mar 16
| ||
Form 4
| -0.65% | -27.00K |
$7.55 | -$203,730.00 | 4.13M |
Scheduled
|
Feb 21 - Feb 22
| ||
Form 4
| -0.99% | -41.48K |
$7.60 | -$315,105.40 | 4.15M |
Scheduled
|
Feb 15 - Feb 17
| ||
Form 4
| -1.61% | -68.48K |
$8.53 | -$584,001.55 | 4.19M |
Scheduled
|
Jan 17 - Jan 20
| ||
Form 4
| -1.42% | -29.66K |
$8.63 | -$255,784.88 | 2.06M |
Jan 17 - Jan 19
| |||
Form 4
| -1.42% | -25.30K |
$8.63 | -$218,222.36 | 1.76M |
Jan 17 - Jan 19
| |||
Form 4
| +3,082.66% | 1.73M |
$6.41 | -$483.00 | 1.78M |
Jun 7
| |||
Form 4
| +3,630.78% | 2.03M |
$6.83 | -$483.00 | 2.09M |
Jun 7
| |||
Form 4
| +3,704.46% | 4.15M |
$6.82 | -$966.00 | 4.26M |
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
G1 Therapeutics, Inc. (GTHX) Snapshot price: $7.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -19.81% | -800.00K |
$48.00 | -$38,400,000.00 | 3.24M |
May 30
| |||
Form 4
| -0.92% | -37.50K |
$51.11 | -$1,916,677.56 | 4.04M |
May 21 - May 23
| |||
Form 4
| -2.36% | -98.52K |
—
|
—
| 4.08M |
Nov 30
| |||
Form 4
|
∞
| 4.17M |
$15.00 |
—
| 4.17M |
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vigil Neuroscience, Inc. (VIGL) Snapshot price: $3.53
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.42% | 36.7K |
$2.85 | $104,410.50 | 1.56M |
May 16 - May 17
| |||
Form 4
|
∞
| 3K |
$7.20 | $21,604.20 | 3K |
Mar 28
| |||
Form 4
|
∞
| 1.52M |
$14.00 |
—
| 1.52M |
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.000001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.38% | 3.75K |
—
|
—
| 36.69K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| +43.59% | 10K |
$3.00 | $30,000.00 | 32.94K |
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
| +27.87% | 5K |
$3.60 | $18,010.00 | 22.94K |
Nov 23 - Nov 24
| |||
Form 4
| -54.31% | -39.67K |
—
|
—
| 33.38K |
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
| -0.12% | -2.91K |
$14.00 | -$40,712.00 | 2.45M |
Scheduled
|
Jul 1
| ||
Form 4
| -0.02% | -400.00 |
$14.00 | -$5,600.00 | 2.45M |
Scheduled
|
Jun 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
| +33.90% | 4K |
$3.13 | $12,520.00 | 15.8K |
Dec 4
| |||
Form 4
|
∞
| 2.46M |
$5.00 |
—
| 2.46M |
Oct 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||